mianserin has been researched along with Obsessive-Compulsive Disorder in 11 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 44-year-old woman with a history of major depression and obsessive-compulsive disorder was prescribed mirtazapine." | 7.72 | Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report. ( Chen, JL; Karwa, M; Spinowitz, N, 2003) |
| "A 44-year-old woman with a history of major depression and obsessive-compulsive disorder was prescribed mirtazapine." | 3.72 | Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report. ( Chen, JL; Karwa, M; Spinowitz, N, 2003) |
| "Biperiden was transiently effective in the acute akathisia, while the more persistent akathisia was alleviated by mianserin." | 1.29 | Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient. ( Meerovich, I; Poyurovsky, M; Weizman, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waltereit, R | 1 |
| Eifler, S | 1 |
| Schirmbeck, F | 1 |
| Zink, M | 1 |
| Conrad, R | 1 |
| Wegener, I | 1 |
| Geiser, F | 1 |
| Imbierowicz, K | 1 |
| Liedtke, R | 1 |
| Egashira, N | 1 |
| Shirakawa, A | 1 |
| Abe, M | 1 |
| Niki, T | 1 |
| Mishima, K | 1 |
| Iwasaki, K | 1 |
| Oishi, R | 1 |
| Fujiwara, M | 1 |
| Kreiss, DS | 1 |
| Coffman, CF | 1 |
| Fiacco, NR | 1 |
| Granger, JC | 1 |
| Helton, BM | 1 |
| Jackson, JC | 1 |
| Kim, LV | 1 |
| Mistry, RS | 1 |
| Mizer, TM | 1 |
| Palmer, LV | 1 |
| Vacca, JA | 1 |
| Winkler, SS | 1 |
| Zimmer, BA | 1 |
| Chen, JL | 1 |
| Spinowitz, N | 1 |
| Karwa, M | 1 |
| Pallanti, S | 1 |
| Quercioli, L | 1 |
| Bruscoli, M | 1 |
| Koran, LM | 2 |
| Gamel, NN | 1 |
| Choung, HW | 1 |
| Smith, EH | 1 |
| Aboujaoude, EN | 1 |
| Poyurovsky, M | 1 |
| Meerovich, I | 1 |
| Weizman, A | 1 |
| Quirk, T | 1 |
| Lorberbaum, JP | 1 |
| Elliott, M | 1 |
| Vïsänen, E | 1 |
| Ranta, P | 1 |
| Nummikko-Pelkonen, A | 1 |
| Tienari, P | 1 |
| De Sousa, MP | 1 |
| Tropa, JR | 1 |
4 trials available for mianserin and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Citalopram; Comorbidity; Depressive Disorder; | 2004 |
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Topics: Adult; Antidepressive Agents, Tricyclic; Diagnostic and Statistical Manual of Mental Disorders; Doub | 2005 |
Mirtazapine treatment of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Female; Humans; Male; Mia | 2001 |
Comparative study of the therapeutic and adverse effects of two antidepressants--dothiepin and mianserin.
Topics: Adjustment Disorders; Adult; Aged; Circadian Rhythm; Depressive Disorder; Dibenzazepines; Dibenzothi | 1986 |
7 other studies available for mianserin and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Visual and auditory hallucinations associated with citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive D | 2013 |
Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.
Topics: Adult; Anorexia Nervosa; Benzodiazepines; Calcinosis; Combined Modality Therapy; Dominance, Cerebral | 2008 |
N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
Topics: Acetylcysteine; alpha-Tocopherol; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Animal | 2012 |
Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
Topics: Animals; Behavior, Animal; Clomipramine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Flu | 2013 |
Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report.
Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Diabetic Ketoacidosis; | 2003 |
Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.
Topics: Adult; Akathisia, Drug-Induced; Biperiden; Fluvoxamine; Follow-Up Studies; Humans; Male; Mianserin; | 1995 |
Mianserin hydrochloride (Org GB 94) in the treatment of obsessional states.
Topics: Adult; Dibenzazepines; Female; Humans; Male; Mianserin; Obsessive-Compulsive Disorder | 1977 |